1. Paralysis agitans of early onset with marked diurinal fluctuation of symptoms;Neurology (Minneap),1973
2. Plasma DOPA and growth hormone in Parkinsonism: oscillations in symptoms;Papavasiliou, P.S.; McDowell, F.A.; Wang, Y.Y.; Rosal, V.; Miller, S.T.;Neurology (Minneap),1979
3. The absorption and metabolism of a standard oral dose of levodopa in patients with Parkinsonism. Br j Clin Pharmacol;Bermann, S.; Curzon, G.; Friedel, J.; Godwin-Austen, R.B.; Marsden, C.D.; Parkes, J.D.,1974
4. Analysis of the clinical problems in Parkinsonism and the complications of long-term levodopa therapy;Lesser, R.P.; Fahn, S.; Snider, SR, Cote; LJ, Isgreen; WP, Barrett; R.E.;Neurology (Minneap); Hornykiewicz 0. Receptor basis for dopaminergic supersensitivity in Parkinson's disease,1979
5. Effects of L-dopa metabolites at a dopamine receptor suggest a basis for "on-off" effect in Parkinson's disease;Dougan, D.; Wade, D.; Mearrick, P.;Nature,1975